Marc Willuhn

Marc Willuhn's work experience includes:

- Managing Director at WILLUHN CONSULTING since August 2018.

- Head of CMC at Opterion Health AG starting in January 2023.

- Director CMC at AnaCardio since September 2021.

- Head of CMC and Manufacturing at Klaria AB from January 2020 onwards.

- Senior CMC Consultant at Klaria AB from February 2019 to December 2019.

- VP CMC at DeckTherapeutics, Inc. since August 2021.

- CMC consultant at DeckTherapeutics, Inc. from March 2020 to August 2021.

- CMC consultant at Sobi - Swedish Orphan Biovitrum AB (publ) from December 2022 onwards.

- Project Director, Tech Transfer at Sobi - Swedish Orphan Biovitrum AB (publ) from March 2021 to December 2022.

- Head, Manufacturing Science & Technology (interim) at Sobi - Swedish Orphan Biovitrum AB (publ) from March 2020 to February 2021.

- CMC consultant at Sobi - Swedish Orphan Biovitrum AB (publ) from January 2020 to March 2020.

- Director End-to-End Supply Haemophilia (interim) at Sobi - Swedish Orphan Biovitrum AB (publ) from November 2018 to December 2019.

- Business Development at MODSIM Pharma AB starting in March 2021.

- Board Member at Biotech Hanse since June 2019.

- Member at Biotech Hanse starting in January 2019.

- Ops Team Member at SmartHealth Catalyzer, Inc. since September 2020.

- Head of Pharmaceutical Development (interim) at Debiopharm from May 2022 to December 2022. In this role, they led a team of approximately 25 people and was responsible for driving CMC strategy and activities for Debiopharm's portfolio of assets from pre-clinical stage to Phase III.

Marc Willuhn's education history begins in 1982 when they completed their Abitur (high school degree) at Gymnasium Rheinkamp. Marc then went on to pursue their Bachelor's degree in Chemistry at the University of Duisburg-Essen from 1991 to 1996. During this time, they also had the opportunity to study at McMaster University for a year as part of their Chemistry program.

After completing their Bachelor's degree, Marc enrolled in two separate institutions to obtain their Doctor of Philosophy (PhD) in Organic Chemistry. From 1996 to 1999, they studied at both the Max-Planck-Institut für Kohlenforschung and the Ruhr University Bochum.

In 2004, Marc decided to expand their educational background by pursuing a Diplomwirtschaftschemiker degree (equivalent to an MBA) in Business Administration and Economics at FernUniversität in Hagen. Marc successfully completed this program in 2008.

In addition to their formal education, Marc also obtained several certifications through online platforms. These include "The Science and Business of Biotechnology," offered by edX and taught by Andrew Lo and Harvey Lodish from MIT (obtained in July 2021), "MITx 7.00x Introduction to Biology - The Secret of Life," taught by Erik Lander from MIT and obtained through edX (obtained in October 2020), "Design and Interpretation of Clinical Trials" and "Game Theory" through Coursera (obtained in April 2015 and December 2014, respectively), as well as "Competitive Strategy" and "Model Thinking" also through Coursera (obtained in May 2014).

It's worth noting that a specific obtained month and year is not provided for the "Model Thinking" certification.